IgA Nephropathy after Nivolumab Therapy for Postoperative Recurrence of Lung Squamous Cell Carcinoma

Immune checkpoint inhibitors (ICIs) are becoming a common and important cancer therapy. ICIs are associated with a unique category of side effects, termed immune-related adverse events (irAEs). We herein report the case of a 72-year-old man with postoperative recurrence of lung squamous cell carcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishi, Seiji, Minato, Masanori, Saijo, Atsuro, Murakami, Naoka, Tamaki, Masanori, Matsuura, Motokazu, Murakami, Taichi, Nagai, Kojiro, Abe, Hideharu, Nishioka, Yasuhiko, Doi, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980806/
https://www.ncbi.nlm.nih.gov/pubmed/29279511
http://dx.doi.org/10.2169/internalmedicine.9814-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980806/
https://www.ncbi.nlm.nih.gov/pubmed/29279511
http://dx.doi.org/10.2169/internalmedicine.9814-17

Ejemplares similares